Literature DB >> 25647294

Association between TNF-α promoter -308 A/G polymorphism and Alzheimer's disease: a meta-analysis.

Young Ho Lee1, Sung Jae Choi, Jong Dae Ji, Gwan Gyu Song.   

Abstract

The aim of this study was to determine whether the tumor necrosis factor-α (TNF-α) promoter -308 A/G polymorphism is associated with susceptibility to Alzheimer's disease (AD) in multi-ethnic populations. MEDLINE and EMBASE databases and manual literature search were used to identify published articles in which TNF-α polymorphism was determined in AD patients and control subjects. Meta-analysis was conducted on the association between the TNF-α -308 A/G polymorphism and AD using allele contrast and the recessive, dominant, and additive models. A total of 16 studies involving 3,826 AD patients and 4,327 control subjects were examined. The meta-analysis showed no association between the TNF-α -308 A allele and AD when all the subjects were considered [odds ratio (OR) = 1.275, 95 % CI 0.966-1.685, p = 0.087]. After stratification by ethnicity, the meta-analysis indicated that the A allele is significantly associated with AD in East Asian (OR = 1.743, 95 % CI 1.256-2.418, p = 0.001), but not in the European (OR = 0.963, 95 % CI 0.822-1.128, p = 0.637) or Middle Eastern populations (OR = 3.921, 95 % CI 0.411-37.42, p = 0.235). Meta-analysis under dominant, recessive, and additive models also showed a similar pattern of results as with the A allele. This meta-analysis shows that the TNF-α -308 A/G polymorphism may represent a significant risk factor for AD in East Asians but not in the European or Middle Eastern populations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25647294     DOI: 10.1007/s10072-015-2102-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  35 in total

Review 1.  Polymorphism of the human TNF-alpha promoter--random variation or functional diversity?

Authors:  R D Allen
Journal:  Mol Immunol       Date:  1999 Oct-Nov       Impact factor: 4.407

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  Effect of proinflammatory gene polymorphisms on the risk of Alzheimer's disease.

Authors:  Andrea Flex; Silvia Giovannini; Federico Biscetti; Rosa Liperoti; Gianfranco Spalletta; Giuseppe Straface; Francesco Landi; Flavia Angelini; Carlo Caltagirone; Giovanni Ghirlanda; Roberto Bernabei
Journal:  Neurodegener Dis       Date:  2013-09-06       Impact factor: 2.977

4.  Estrogen receptor alpha gene variants are associated with Alzheimer's disease.

Authors:  Mercé Boada; Carmen Antunez; Jesús López-Arrieta; Antonio Caruz; Concha Moreno-Rey; Reposo Ramírez-Lorca; Francisco Jesús Morón; Isabel Hernández; Ana Mauleón; Maiteé Rosende-Roca; Pablo Martínez-Lage; Juan Marín; Lluis Tárraga; Montserrat Alegret; José Rafael Pedrajas; Nuria Urda; José Luis Royo; María Eugenia Saez; Javier Gayán; Antonio González-Pérez; Luis Miguel Real; Agustín Ruiz; José Jorge Galán
Journal:  Neurobiol Aging       Date:  2010-07-31       Impact factor: 4.673

5.  Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls.

Authors:  R T Perry; J S Collins; L E Harrell; R T Acton; R C Go
Journal:  Am J Med Genet       Date:  2001-05-08

Review 6.  Polymorphisms in inflammatory genes and the risk of Alzheimer disease.

Authors:  P L McGeer; E G McGeer
Journal:  Arch Neurol       Date:  2001-11

Review 7.  Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease.

Authors:  Danilo Di Bona; Giuseppina Candore; Claudio Franceschi; Federico Licastro; Giuseppina Colonna-Romano; Calogero Cammà; Domenico Lio; Calogero Caruso
Journal:  Brain Res Rev       Date:  2009-05-13

8.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

9.  PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis.

Authors:  Young Ho Lee; Young Hee Rho; Seong Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2007-01-31       Impact factor: 3.580

10.  Genetic association of TNF-α-308 G/A and -863 C/A polymorphisms with late onset Alzheimer's disease in Azeri Turk population of Iran.

Authors:  Seiied Moitaba Mohaddes Ardebili; Tarlan Yeghaneh; Jalal Gharesouran; Maryam Rezazadeh; Mehdi Farhoudi; Hormoz Ayromlou; Mahnaz Talebi; Morteza Ghojazadeh
Journal:  J Res Med Sci       Date:  2011-08       Impact factor: 1.852

View more
  5 in total

Review 1.  The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ.

Authors:  Cong Zheng; Xin-Wen Zhou; Jian-Zhi Wang
Journal:  Transl Neurodegener       Date:  2016-04-05       Impact factor: 8.014

Review 2.  Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms.

Authors:  Fan Su; Feng Bai; Zhijun Zhang
Journal:  Neurosci Bull       Date:  2016-08-27       Impact factor: 5.203

Review 3.  Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors.

Authors:  Mariana F Uchoa; V Alexandra Moser; Christian J Pike
Journal:  Front Neuroendocrinol       Date:  2016-09-17       Impact factor: 8.606

Review 4.  Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis of Alzheimer's Disease.

Authors:  Julia Doroszkiewicz; Piotr Mroczko; Agnieszka Kulczyńska-Przybik
Journal:  Curr Alzheimer Res       Date:  2022       Impact factor: 3.040

5.  High doses of minocycline may induce delayed activation of microglia in aged rats and thus cannot prevent postoperative cognitive dysfunction.

Authors:  Wenyao Li; Qing Chai; Hongwei Zhang; Jing Ma; Chengfen Xu; Jifu Dong; Xianghua Wei; Zhiyi Wang; Kexian Zhang
Journal:  J Int Med Res       Date:  2018-02-19       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.